Filtered By:
Management: Funding
Countries: Saudi Arabia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Diabetes mellitus research in Saudi Arabia: A bibliometric study (2010-2021)
This study examines KSA's DM research during 2010-2021. Data were acquired from Scopus and analyzed using VOSviewer and MS Excel. Several characteristics were examined to measure the quantity and quality of KSA-related DM articles. In total, 1,919 journal and conference papers were published. DM research included researchers from multidisciplinary sectors. Thirty-seven percent of them have ten or more scientific publications. Al-Daghri, N.M. (King Saud University) leads the pack. In total, 757 (39.44%) research projects got funding from 159 sources within and outside KSA. Memish, Z.A. is the most cited author. The Saudi Me...
Source: Primary Care - August 28, 2023 Category: Primary Care Authors: Siddig Ibrahim Abdelwahab Manal Mohamed Elhassan Taha Yahia Ali Kaabi Source Type: research
Long-running ProMED email service for alerting world to disease outbreaks is in trouble
The first news about the COVID-19 pandemic came not from a government or a scientific publication, but in an email from a disease-alert system called
ProMED
. This fateful missive in December 2019 about a few cases of a mysterious pneumonia in Wuhan, China, is just one example of how physicians and public health experts around the world have used the 30-year-old, free service to share real-time information about local disease outbreaks with tens of thousands of subscribers.
But ProMED is now on life support. Much of its work came to a screeching halt yesterday when 21 of its 38 paid editors and moderators went o...
Source: Science of Aging Knowledge Environment - August 4, 2023 Category: Geriatrics Source Type: research
Author Correction: Association of monomeric C-Reactive Protein (m-CRP) with hypothalamic neurons after CRP hippo-campal administration in a model of dementia
Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):443. doi: 10.26355/eurrev_202301_31044.ABSTRACTCorrection to: European Review for Medical and Pharmacological Sciences 2022; 26 (22): 8713-8718. DOI: 10.26355/eurrev_202212_30543- PMID: 36524490-published online on December 15, 2022. After publication, the authors applied a correction to the funding statement: The authors extend their appreciation to the deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number (lFP-2020-36). There are amendments to this paper. The Publisher apologizes for any inconveni...
Source: Pharmacological Reviews - February 3, 2023 Category: Drugs & Pharmacology Authors: R S Al-Baradie A Abdel-Hadi F Ahmad S A Alsagaby M Slevin W Alturaiki Y Madkhali B M Aljarallah M Alqahtani M Miraj I Ahmad N Albaradie R Albaradie Source Type: research
Inside the Effort to Promote Abortion Pills For a Post-Roe America
If the Supreme Court overturns Roe v. Wade this summer, as a leaked draft opinion suggests it may, abortion will likely be banned or severely restricted in about half of the United States. But that doesn’t necessarily mean the country will return to a world before 1973, when the landmark Supreme Court case enshrined a constitutional right to abortion.
Abortion pills, which can be ordered online and delivered by mail, have already fundamentally changed reproductive rights in America. The regimen of two drugs, mifepristone and misoprostol, can in theory be safely taken anywhere, including in the privacy of people&rsquo...
Source: TIME: Health - May 31, 2022 Category: Consumer Health News Authors: Abigail Abrams and Jamie Ducharme Tags: Uncategorized abortion feature healthscienceclimate Source Type: news
Living well with kidney disease by patient and care-partner empowerment: Kidney health for everyone everywhere
Saudi J Kidney Dis Transpl. 2021 Mar-Apr;32(2):289-297. doi: 10.4103/1319-2442.335439.ABSTRACTLiving with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 th...
Source: Saudi Journal of Kidney Diseases and Transplantation - January 12, 2022 Category: Urology & Nephrology Authors: Kamyar Kalantar-Zadeh Philip Kam-Tao Li Ekamol Tantisattamo Latha Kumaraswami Vassilios Liakopoulos Siu-Fai Lui Ifeoma Ulasi Sharon Andreoli Alessandro Balducci Sophie Dupuis Tess Harris Anne Hradsky Richard Knight Sajay Kumar Maggie Ng Alice Poidevin Gam Source Type: research
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
In this study, we tested whether sevuparin could shorten vaso-occlusive crisis duration in hospitalised patients with sickle cell disease.METHODS: We did a multicentre, double-blinded, placebo-controlled, phase 2 study in 16 public access clinical hospitals in the Netherlands, Lebanon, Turkey, Bahrain, Oman, Saudi Arabia, and Jamaica. Patients aged 12-50 years with a diagnosis of sickle cell disease (types HbSS, HbSC, HbSβ0-thalassaemia, or HbSβ+-thalassaemia) on a stable dose of hydroxyurea, hospitalised with vaso-occlusive crisis for parenteral opioid analgesia with a projected stay of more than 48 h were included in t...
Source: Pain Physician - April 24, 2021 Category: Anesthesiology Authors: Bart J Biemond Anil Tombak Yurdanur Kilinc Murtadha Al-Khabori Miguel Abboud Mohammed Nafea Adlette Inati Yasser Wali Jens Kristensen Jan Kowalski Ellen Donnelly John Ohd TVOC01 Investigators Group Source Type: research
